WAGG, A.; FRANKS, B.; RAMOS, B.; BERNER, T. Persistence and adherence with the new beta-3 receptor agonist, mirabegron, versus antimuscarinics in overactive bladder: Early experience in Canada. Canadian Urological Association Journal, v. 9, n. 9-10, p. 343-50, 13 Oct. 2015.